» Articles » PMID: 32732938

Immune Network Dysregulation Precedes Clinical Diagnosis of Asthma

Overview
Journal Sci Rep
Specialty Science
Date 2020 Aug 1
PMID 32732938
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Allergic asthma is a chronic disease beginning in childhood that is characterized by dominant T-helper 2 cell activation without adequate counter-regulation by T-helper 1 cell and regulatory T cell activity. Prior transcriptomic studies of childhood asthma have primarily investigated subjects who already have a disease diagnosis, and have generally taken an approach of differential gene expression as opposed to differential gene interactions. The immune states that predispose towards allergic sensitization and disease development remain ill defined. We thus characterize immune networks of asthmatic predisposition in children at the age of 2, prior to the diagnosis of allergic asthma, who are subsequently diagnosed with asthma at the age of 7. We show extensive differences of gene expression networks and gene regulatory networks in children who develop asthma versus those who do not using transcriptomic data from stimulated peripheral blood mononuclear cells. Moreover, transcription factors that bind proximally to one another share patterns of dysregulation, suggesting that network differences prior to asthma diagnosis result from altered accessibility of gene targets. In summary, we demonstrate non-allergen-specific immune network dysregulation in individuals long before clinical asthma diagnosis.

Citing Articles

Risk of long covid in patients with pre-existing chronic respiratory diseases: a systematic review and meta-analysis.

Terry P, Heidel R, Wilson A, Dhand R BMJ Open Respir Res. 2025; 12(1).

PMID: 39884720 PMC: 11784193. DOI: 10.1136/bmjresp-2024-002528.


BORN TO WHEEZE OR LEARNED WHEN WE WERE YOUNG: MATERNAL AND ENVIRONMENTAL FACTORS INFLUENCE ATOPIC RISK.

Finn P, Perkins D Trans Am Clin Climatol Assoc. 2023; 133:181-192.

PMID: 37701609 PMC: 10493753.


Childhood asthma phenotypes and endotypes: a glance into the mosaic.

Foppiano F, Schaub B Mol Cell Pediatr. 2023; 10(1):9.

PMID: 37646843 PMC: 10469115. DOI: 10.1186/s40348-023-00159-1.

References
1.
Gunawardhana L, Gibson P, Simpson J, Powell H, Baines K . Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma. Clin Exp Allergy. 2013; 44(1):47-57. DOI: 10.1111/cea.12168. View

2.
Reese S, Xu C, den Dekker H, Lee M, Sikdar S, Ruiz-Arenas C . Epigenome-wide meta-analysis of DNA methylation and childhood asthma. J Allergy Clin Immunol. 2018; 143(6):2062-2074. PMC: 6556405. DOI: 10.1016/j.jaci.2018.11.043. View

3.
Wu L, Cao J, Cai W, Lang S, Horton J, Jansen D . KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol. 2018; 16(8):e2006134. PMC: 6095604. DOI: 10.1371/journal.pbio.2006134. View

4.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

5.
Su R, Becker A, Kozyrskyj A, HayGlass K . Epigenetic regulation of established human type 1 versus type 2 cytokine responses. J Allergy Clin Immunol. 2007; 121(1):57-63.e3. DOI: 10.1016/j.jaci.2007.09.004. View